Genomic analysis of known breast cancer genes revealed that 11.9% (10/84) patients carried an unambiguously pathogenic germline mutation in three genes: BRCA1, BRCA2, and TP53 (Table 2). This evidence concerns the gene TP53 and breast carcinoma.